Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells.
Passer BJ; Castelo-Branco P; Buhrman JS; Varghese S; Rabkin SD; Martuza RL; Cancer Gene Therapy, 2009, vol. 16, issue 7, p 551, ISSN 14765500. ISBN 14765500.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef